Cargando…

Cost Effectiveness of Screening Strategies for Early Identification of HIV and HCV Infection in Injection Drug Users

OBJECTIVE: To estimate the cost, effectiveness, and cost effectiveness of HIV and HCV screening of injection drug users (IDUs) in opioid replacement therapy (ORT). DESIGN: Dynamic compartmental model of HIV and HCV in a population of IDUs and non-IDUs for a representative U.S. urban center with 2.5...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cipriano, Lauren E., Zaric, Gregory S., Holodniy, Mark, Bendavid, Eran, Owens, Douglas K., Brandeau, Margaret L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2012
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3445468/ https://www.ncbi.nlm.nih.gov/pubmed/23028828 http://dx.doi.org/10.1371/journal.pone.0045176

Ejemplares similares

Effectiveness and Cost Effectiveness of Oral Pre-Exposure Prophylaxis in a Portfolio of Prevention Programs for Injection Drug Users in Mixed HIV Epidemics
por: Alistar, Sabina S., et al.
Publicado: (2014)

Cost-effectiveness of malaria preventive treatment for HIV-infected pregnant women in sub-Saharan Africa
por: Choi, Sung Eun, et al.
Publicado: (2017)

Estimation of the cost-effectiveness of HIV prevention portfolios for people who inject drugs in the United States: A model-based analysis
por: Bernard, Cora L., et al.
Publicado: (2017)

Effectiveness and Cost Effectiveness of Expanding Harm Reduction and Antiretroviral Therapy in a Mixed HIV Epidemic: A Modeling Analysis for Ukraine
por: Alistar, Sabina S., et al.
Publicado: (2011)

Hepatitis C virus (HCV) infection and re-infection among HCV- and HIV/HCV-infected injection drug users
por: Conway, B, et al.
Publicado: (2010)

Molecular Epidemiology of HCV Monoinfection and HIV/HCV Coinfection in Injection Drug Users in Liuzhou, Southern China
por: Tan, Yi, et al.
Publicado: (2008)

Detection of HCV-Specific IFN-γ Responses in HCV Antibody and HCV RNA Negative Injecting Drug Users
por: Flynn, Jacqueline K, et al.
Publicado: (2014)

HCV monoinfection and HIV/HCV coinfection enhance T-cell immune senescence in injecting drug users early during infection
por: Grady, Bart P. X., et al.
Publicado: (2016)

Immune Biomarker Differences and Changes Comparing HCV Mono-Infected, HIV/HCV Co-Infected, and HCV Spontaneously Cleared Patients
por: Kushner, Lauren E., et al.
Publicado: (2013)

Cost-Effectiveness Analysis of Risk-Factor Guided and Birth-Cohort Screening for Chronic Hepatitis C Infection in the United States
por: Liu, Shan, et al.
Publicado: (2013)

Frequency of HBV, HCV and HIV infections among hospitalized injecting drug users in Kashan
por: Sharif, M., et al.
Publicado: (2009)

Risk of Cardiovascular Disease from Antiretroviral Therapy for HIV: A Systematic Review
por: Bavinger, Clay, et al.
Publicado: (2013)

Epidemic dispersion of HIV and HCV in a population of co-infected Romanian injecting drug users
por: Paraschiv, Simona, et al.
Publicado: (2017)

High HCV seroprevalence and HIV drug use risk behaviors among injection drug users in Pakistan
por: Kuo, Irene, et al.
Publicado: (2006)

HIV/HCV co-infection and associated risk factors among injecting drug users in Dar es Salaam, Tanzania: potential for HCV elimination
por: Leyna, Germana Henry, et al.
Publicado: (2019)

Control over Drug Acquisition, Preparation, and Injection: Implications for HIV and HCV Risk among Young Female Injection Drug Users
por: Wagner, Karla D., et al.
Publicado: (2013)

Anticipated burden and mitigation of carbon-dioxide-induced nutritional deficiencies and related diseases: A simulation modeling study
por: Weyant, Christopher, et al.
Publicado: (2018)

Consistency of spatial dynamics of HIV-1 and HCV among HIV-1/HCV coinfected drug users in China
por: Wang, Yu, et al.
Publicado: (2021)

Elimination of hepatitis C virus in Germany: modelling the cost-effectiveness of HCV screening strategies
por: Krauth, Christian, et al.
Publicado: (2019)

Comparison of HCV viral load and its genotype distributions in HCV mono- and HIV/HCV co-infected illicit drug users
por: Jamalidoust, Marzieh, et al.
Publicado: (2017)

Prevalence of HIV and HCV among injecting drug users in three selected WHO-EMRO countries: a meta-analysis
por: Shayan, Shah Jahan, et al.
Publicado: (2021)

HCV Subtype Characterization among Injection Drug Users: Implication for a Crucial Role of Zhenjiang in HCV Transmission in China
por: Zhang, Chiyu, et al.
Publicado: (2011)

Population Health and Cost-Effectiveness Implications of a “Treat All” Recommendation for HCV: A Review of the Model-Based Evidence
por: Cipriano, Lauren E., et al.
Publicado: (2018)

The Molecular Epidemiological Study of HCV Subtypes among Intravenous Drug Users and Non-Injection Drug Users in China
por: Tao, Jun, et al.
Publicado: (2015)

Cost-Effectiveness of HBV and HCV Screening Strategies – A Systematic Review of Existing Modelling Techniques
por: Geue, Claudia, et al.
Publicado: (2015)

Prevalences and associated risk factors of HCV/HIV co-infection and HCV mono-infection among injecting drug users in a methadone maintenance treatment program in Taipei, Taiwan
por: Yen, Yung-Feng, et al.
Publicado: (2012)

Structural sensitivity in HIV modeling: A case study of vaccination
por: Bernard, Cora L., et al.
Publicado: (2017)

Expanded HIV Testing in Low-Prevalence, High-Income Countries: A Cost-Effectiveness Analysis for the United Kingdom
por: Long, Elisa F., et al.
Publicado: (2014)

Hepatitis C virus (HCV) infection & risk factors for HCV positivity in injecting & non-injecting drug users attending a de-addiction centre in northern India
por: Basu, Debasish, et al.
Publicado: (2015)

Strategies for recruiting injection drug users for HIV prevention services in Delhi, India
por: Tun, Waimar, et al.
Publicado: (2013)

Designing an experimental HIV/HCV intervention to promote the safe re-use of drug preparation materials by injection drug users in Puerto Rico
por: Finlinson, H Ann, et al.
Publicado: (2008)

High Prevalence of HIV, HCV, HBV and Co-Infection and Associated Risk Factors among Injecting Drug Users in Yunnan Province, China
por: Zhou, Yan-Heng, et al.
Publicado: (2012)

Modeling the Cost-Effectiveness of Interventions to Prevent Plague in Madagascar
por: Malloy, Giovanni S. P., et al.
Publicado: (2021)

Mitral valve endocarditis in an IV ethnobotanical drug user coinfected with HIV-HCV
por: Popa, Ionut, et al.
Publicado: (2014)

HIV and HCV Infection Status Among Drug Users — China, 2010−2018
por: Ge, Lin, et al.
Publicado: (2020)

Comparative effectiveness and cost-effectiveness of antiretroviral therapy and pre-exposure prophylaxis for HIV prevention in South Africa
por: Alistar, Sabina S, et al.
Publicado: (2014)

Multiple Introduction and Naturally Occuring Drug Resistance of HCV among HIV-Infected Intravenous Drug Users in Yunnan: An Origin of China’s HIV/HCV Epidemics
por: Chen, Min, et al.
Publicado: (2015)

Social determinants and risk behaviors associated with prevalent Hepatitis C and HIV/HCV co-infection among male injection drug users in Nepal
por: Kakchapati, Sampurna, et al.
Publicado: (2017)

Prevention and control of dengue and chikungunya in Colombia: A cost-effectiveness analysis
por: Claypool, Anneke L., et al.
Publicado: (2021)

Diverse HCV Strains And HIV URFS Identified Amongst People Who Inject Drugs In India
por: Rodgers, Mary A., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_84r35gftbmpd0cm7pdhhrrdhv1